In the past few decades, the frequency of immunodeficiency-associated BL has increased owing to the number of HIV-positive patients, posttransplantation patients or those undergoing immunosuppressive therapy. The presentation of this variant is often in the peripheral lymph nodes and bone marrow, with 40-50% of the patients being positive for EBV [7] .
In Mexico, the annual incidence of BL is estimated to be one to two cases per 10 6 children/year [8] [9] [10] , with only one report describing some clinical and epidemiological characteristics of these cases [11] . Although sporadic BL may be expected to predominate in Mexico as in other non-African countries [12] , distinct socioeconomic conditions may cause differences in the clinical and epidemiological characteristics, as has been seen for Hodgkin lymphoma in Mexico [13] .
Here, we describe some clinical and epidemiological characteristics of childhood BL, which were determined by analyzing data from the Childhood Cancer Register of the Instituto Mexicano del Seguro Social (CCR-IMSS), according to two defined socioeconomic regions.
M A T E R I A L A N D M E T H O D S
For inclusion in this study, cases had to fulfill the following criteria: age <15 years at diagnosis, registered in the CCR-IMSS during the period 1 January 1996 to 31 December 2013, with diagnosis of BL confirmed by histopathology (morphological classification according to the International Classification of Diseases for Oncology Third Edition) [14] , and to have resided within Mexico City or the states of Mexico, Chiapas, Guerrero or Morelos. These political jurisdictions send their pediatric cancer patients to tertiary-care medical centers in Mexico City for cancer treatment. The population data are obtained on the basis of the system that enumerates the insured persons: in general, the population enrolled in the IMSS represents 40% of the inhabitants aged <15 years in each of these jurisdictions.
We grouped the jurisdictions into regions defined as having high or low socioeconomic level. Data for this classification were obtained from the Instituto Nacional de Estad ıstica y Geograf ıa de México [15] , an institution that determines the hierarchy of socioeconomic levels, based on indicators of wellbeing such as the education, occupation, health, housing and degree of employment of the population in an area. Levels were ranked 1-7, with 1 being the lowest and 7, the highest. Therefore, we grouped Mexico City and the State of Mexico (ranked 7 and 5, respectively) into the high socioeconomic region (HSER) and Chiapas, Guerrero and Morelos (ranked 1, 1 and 4, respectively) into the low socioeconomic region (LSER). The latter, although not a poor state, has its location in the southern region, and has border with Guerrero State.
For each patient, the information obtained from the CCR-IMSS included gender, place of residence (jurisdiction), age at diagnosis, symptoms at diagnosis, clinical stage according to the classification of St. Jude Children's Research Hospital [16] and time to diagnosis (TDg). The TDg was defined as the weeks that passed from the first manifestation of symptoms associated with BL, as detected by the parents or caregivers, to the date that a physician suspected a neoplasm. The cases were analyzed based on the patient's residence in the HSER or LSER.
We calculated the general frequency of the variables and the overall incidence, and specific incidences by gender, age group (<1, 1-4, 5-9 and 10-14 years) and socioeconomic region. The incidence rates were calculated by using, as denominator, the population enrolled in the IMSS system in each jurisdiction during the period 1996-2013 [17] . For the regional population, we add the populations of their jurisdictions. The overall incidence was adjusted according to age by using the direct method, with the world population taken as reference; incidence rates are given per 10 6 children/year [18] . We used the Fisher exact test or the v 2 test to contrast the differences in the distribution of the clinical stages between the two socioeconomic regions. For the TDg, the medians and interquartile ranges (IQRs) were computed; comparisons between regions were analyzed by using the nonparametric Mann-Whitney U test. A value of p < 0.05 was considered as being statistically significant. The analysis was carried out with the statistical packet SPSSv20 (USA).
The Committee of Investigation and Ethics of IMSS authorized this project (R-2012-3603-56).
R E S U L T S
Of the 63 cases of BL registered during this 18-year period (1996-2013), 45 (71.4%) were from the HSER and 18 (28.6%) from the LSER. The overall incidence was 1.7 (CI 95% : 1.2, 2.1), with the incidence being higher in the LSER than in the HSER [3.1 (CI 95% : 1.8, 4.9) vs. 1.4 (CI 95% : 1.0, 1.8), respectively; p ¼ 0.05]. In the LSER, the peak incidence was highest for the 1-4-year-old group, whereas in the HSER, for the 5-9-year-olds (p ¼ 0.008), a difference was found not only in the analysis of frequencies (Table 1 ), but also in the comparison of the incidence rates ( Figure 1 ). The majority of the patients were males (M/F ¼ 1.9), with the ratio being higher in the LSER (5.0) than in the HSER (1.4) ( Table 2) .
As for the clinical presentation, in 44 (69.8%) of the cases, masses were primarily located in the abdominal area, without a statistically significant difference between regions. Involvement of the head and neck was observed in only 11% of cases. In the majority (61.9%; 39/63) of cases, the tumors had extranodal involvement, also without differences between regions. Owing to the location of the tumors, the predominant symptoms were abdominal pain, with other abdominal manifestations such as constipation, diarrhea and distension. In addition, other generalized symptoms such as asthenia, adynamia and anorexia were manifested (Table 1) . Although not statistically significant (p ¼ 0.10), the greatest difference in the clinical data was the presence of B symptoms, which were more common in the LSER (53.3% vs. 25.7; p ¼ 0.10). There was only one case (1.6%) of immunodeficiency-associated BL, that of a 12-year-old girl after renal transplant in the HSER.
The register showed that it had been possible to determine the clinical stage at diagnosis for only 53 (84.1%) of the patients (Table 1) . Of these, 83.0% were presented in advanced stages (III/IV), without differences between regions (p ¼ 0.69). The 10 cases that had not been staged corresponded principally to the period before 1996-1997 and, in particular, to the HSER.
Analysis by socioeconomic regions showed similar values for TDg: overall, the median values were 4.6 (IQR: 2.6-12.0) weeks for the HSER vs. 
D I S C U S S I O N
We found that BL in these pediatric Mexican patients was predominantly the sporadic variant (abdominal). These data are consistent with the sporadic variant of BL, such as has been encountered in regions other than equatorial Africa [3, 29, 30] . In addition, we found only one case (1.6%) to have been associated with immunosuppressive treatment after renal transplant, as it was informed in other reports [7] . The endemic variety, which is found in all P. falciparum holoendemic areas of sub-Saharan Africa, such as Uganda and Tanzania [30, 31] , has been explained by co-infection with malaria and EBV [2] ; however, these infections do not have to be present at the onset of lymphoma. In Mexico, the only region of high risk for malaria is in the state of Chiapas, on Mexico's southern border with Guatemala [32] ; however, we consider that the five patients referred from that area were sporadic form because they had abdominal diseases and not history or current evidence of malaria; although EBV infection may have been possible. To establish whether an endemic variety of BL exists in these sites, we plan to carry out a more extensive study by including new data obtained in the past few years.
The principal finding of this study was a difference in the incidence of BL between the regions studied. The incidence (1.4) in the HSER was similar to those reported for countries such as South Africa (Black population) [20] , Taiwan [19] , Thailand [25] and Switzerland [28] , whereas the incidence (3.1) in the LSER was closer to the value reported for South Africa (White population) [20] , Germany [23] and, to a lesser extent, to those reported for Argentina [22] and the USA [21] (Table  2) . Both values are lower than the incidences for European countries such as France [27] and Spain [26] , where migrant populations from Africa may affect the incidence (Table 2 ). If we assume that there are no problems with cancer registers, the differences may be related to issues of race, geographic situation and/or health-care access.
It has been documented that, worldwide, males are affected at a higher frequency by this neoplasm; however, the M/F ratios vary by country (Table 2) . For the LSER, we found a M/F ratio of 5.0, similar to that for Germany [23] , France [27] and Switzerland [28] ; for the HSER, the M/F ratio was lower (1.4), similar to that for South African White population [20] . We do not have an explanation for this difference, but it could be associated with different genetic and biological exposures, given that the HSER is more urban, whereas the LSER is more rural.
The peak presentation of BL for the LSER (1-4-year-olds) was similar to those in developing countries such as Brazil [24] and Thailand [25] and in the Black population of South Africa [20] . In contrast, the peak presentation of BL for the HSER (5-9-year-olds) was similar to those found for European countries (e.g. Germany, France and Spain) [23, 27, 26] , Argentina [22] and the USA [29] . This phenomenon may be associated with the moment of the infection by EBV, which could occur earlier in a region with a lower socioeconomic level and later in a region with a higher level [33] . This phenomenon is similar to that observed for Hodgkin lymphomas in Mexico [13] and other countries [2, 34] , where the major incidence peak was found for 1-4-years-old group in the LSER and for the older age group (5-9 years) for the HSER. The high proportion of the patients diagnosed as being in an advanced stage (III/IV), with no differences between regions, is consistent with the values (68-86% of cases) reported for distinct regions of the world [3, 35] . Exceptions to the foregoing are Taiwan [36] and China [37] , for which higher frequencies of cases at Stage I/II (43 and 65.1%, respectively) were found at diagnosis; however, those were not population-based studies and may have been subject to selection bias.
Although not statistically significant, the finding that the TDg for the cases in Stages I and II was greater than that for those in Stages III and IV supports the concept that the aggressiveness of a tumor plays a role: greater aggressiveness may produce severer symptomatology or greater anxiety in the parents, thereby leading to a prompter search for medical attention, which, in turn, can lead to more rapid medical diagnosis on the part of health-care personnel. Given that the TDg for patients in the LSER had a longer, but not statistically significant, delay, the difference in TDg for Stages I/II between the regions studied may be attributed to administrative factors, as it is known that the distance to the specialized medical centers increases the TDg [38] .
The principal strength of this study is the prospective, population-based character of the CCR-IMSS and the quality of the data contained [39] . To better determine the association between pediatric BL and infection with EBV and to determine if such association is related to the age at presentation, it will be necessary to carry out a study of the seroprevalence of EBV in the pediatric population [33] .
The following are limitations to this study. These data cannot be extrapolated to the entire Mexican population because although the IMSS system represents, in general, the bulk of the Mexican population (i.e. the working population), there is a low representation of the poor population and of the rich. As this is the first report of the epidemiology of pediatric BL in Mexico, it was therefore not possible to evaluate its consistency with other populations of Mexicans. Also, the estimated rates have low precision, given the low frequency of this tumor.
We conclude that BL in the regions studied was predominantly from the sporadic variant, with a high frequency of abdominal presentation and with diagnosis being made at advanced stages. The incidence, although within the range of values reported worldwide, was higher in the region having a lower socioeconomic level.
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